Skip to main content

Table 4 Additional specificity testing of aberrantly methylated genes in colon cancer in the test and validation sets

From: Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

 

Specificity in colon cancer

 

Test set

Validation set

Gene

Methylation

negative

%

Methylation

negative

%

DKK3

27 of 27

100

24 of 31

77

ITIH5

24 of 27

89

22 of 31

71

WIF1

23 of 27

85

n.d.

 

SFRP1

16 of 22

73

n.d.

 

SFRP2

22 of 26

85

n.d.

 

SFRP5

n.d.

 

n.d.

 

RASSF1A

n.d.

 

13 of 31

42

DKK3/ITIH5 a

24 of 27

88

16 of 31

52

Three-gene panela

n.d.

 

6 of 31

19

  1. aEither gene methylated. n.d., not done.